New drug cocktail shows promise for Hard-to-Treat myeloma

This study tested a combination of four drugs (elotuzumab, carfilzomib, lenalidomide, and dexamethasone) in 15 people whose multiple myeloma had returned or stopped responding to treatment. The goal was to see if this experimental mix could shrink the cancer more effectively than existing options. Participants received the drugs in cycles, and researchers measured how many achieved a very good partial response or better.